The NF-κB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells. 2017

Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Coronavirus replication takes place in the host cell cytoplasm and triggers inflammatory gene expression by poorly characterized mechanisms. To obtain more insight into the signals and molecular events that coordinate global host responses in the nucleus of coronavirus-infected cells, first, transcriptome dynamics was studied in human coronavirus 229E (HCoV-229E)-infected A549 and HuH7 cells, respectively, revealing a core signature of upregulated genes in these cells. Compared to treatment with the prototypical inflammatory cytokine interleukin(IL)-1, HCoV-229E replication was found to attenuate the inducible activity of the transcription factor (TF) NF-κB and to restrict the nuclear concentration of NF-κB subunits by (i) an unusual mechanism involving partial degradation of IKKβ, NEMO and IκBα and (ii) upregulation of TNFAIP3 (A20), although constitutive IKK activity and basal TNFAIP3 expression levels were shown to be required for efficient virus replication. Second, we characterized actively transcribed genomic regions and enhancers in HCoV-229E-infected cells and systematically correlated the genome-wide gene expression changes with the recruitment of Ser5-phosphorylated RNA polymerase II and prototypical histone modifications (H3K9ac, H3K36ac, H4K5ac, H3K27ac, H3K4me1). The data revealed that, in HCoV-infected (but not IL-1-treated) cells, an extensive set of genes was activated without inducible p65 NF-κB being recruited. Furthermore, both HCoV-229E replication and IL-1 were shown to upregulate a small set of genes encoding immunomodulatory factors that bind p65 at promoters and require IKKβ activity and p65 for expression. Also, HCoV-229E and IL-1 activated a common set of 440 p65-bound enhancers that differed from another 992 HCoV-229E-specific enhancer regions by distinct TF-binding motif combinations. Taken together, the study shows that cytoplasmic RNA viruses fine-tune NF-κB signaling at multiple levels and profoundly reprogram the host cellular chromatin landscape, thereby orchestrating the timely coordinated expression of genes involved in multiple signaling, immunoregulatory and metabolic processes.

UI MeSH Term Description Entries
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002843 Chromatin The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell. Chromatins
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D047369 Chromatin Immunoprecipitation A technique for identifying specific DNA sequences that are bound, in vivo, to proteins of interest. It involves formaldehyde fixation of CHROMATIN to crosslink the DNA-BINDING PROTEINS to the DNA. After shearing the DNA into small fragments, specific DNA-protein complexes are isolated by immunoprecipitation with protein-specific ANTIBODIES. Then, the DNA isolated from the complex can be identified by PCR amplification and sequencing. Immunoprecipitation, Chromatin
D059467 Transcriptome The pattern of GENE EXPRESSION at the level of genetic transcription in a specific organism or under specific circumstances in specific cells. Transcriptomes,Gene Expression Profiles,Gene Expression Signatures,Transcriptome Profiles,Expression Profile, Gene,Expression Profiles, Gene,Expression Signature, Gene,Expression Signatures, Gene,Gene Expression Profile,Gene Expression Signature,Profile, Gene Expression,Profile, Transcriptome,Profiles, Gene Expression,Profiles, Transcriptome,Signature, Gene Expression,Signatures, Gene Expression,Transcriptome Profile

Related Publications

Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
August 1986, British journal of experimental pathology,
Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
June 2023, Microbiology spectrum,
Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
January 2021, PloS one,
Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
January 1993, Advances in experimental medicine and biology,
Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
January 1993, Advances in experimental medicine and biology,
Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
November 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
June 1978, The Journal of general virology,
Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
September 1980, Journal of clinical microbiology,
Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
January 2021, Frontiers in cell and developmental biology,
Michael Poppe, and Sascha Wittig, and Liane Jurida, and Marek Bartkuhn, and Jochen Wilhelm, and Helmut Müller, and Knut Beuerlein, and Nadja Karl, and Sabin Bhuju, and John Ziebuhr, and M Lienhard Schmitz, and Michael Kracht
January 2001, Advances in experimental medicine and biology,
Copied contents to your clipboard!